Masahiro Oda

Masahiro Oda is a seasoned professional in the biopharmaceutical industry, currently serving as Senior Director at Cytiva since May 2023. Oda has extensive experience with Pall Corporation, holding multiple leadership roles including Senior Director for Pall Biotech APAC Gene Therapy and Business Director from 1992 to May 2023. In addition, Oda has been actively involved with PDA Japan on the Virus Safety Committee since March 2003 and served on the ISPE Global Steering Committee until October 2020. Oda's education includes the completion of the Sustainable Business Strategy program and the CORe Credential of Readiness from Harvard Business School Online, along with studies at Tokyo University of Science.